About ACM Biolabs
ACM Biolabs is a company based in Singapore (Singapore) founded in 2012 by Madhavan Nallani. ACM Biolabs offers products and services including ATP™ Platform. ACM Biolabs operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, GSK, Avidity Biosciences and Generate Biomedicines, among others.
- Headquarter Singapore, Singapore
- Founders Madhavan Nallani
-
Sectors
HealthcareChemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acm Biolabs Pte. Ltd.
-
Annual Revenue
$33.72 K (USD)0as on May 31, 2018
-
Net Profit
-$1.02 M (USD)2as on May 31, 2019
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
NTUitive
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ACM Biolabs
ACM Biolabs offers a comprehensive portfolio of products and services, including ATP™ Platform.
Hybrid platform for targeted delivery of drug payloads like mRNA and proteins.
Funding Insights of ACM Biolabs
Investors in ACM Biolabs
ACM Biolabs has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include NTUitive and Venturelab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups across technologies and sectors are incubated by university-backed NTUitive.
|
Locked | Locked | Locked | |
|
Swiss startups are supported through innovative programs by Venturelab.
|
Locked | Locked | Locked |
Investor details for ACM Biolabs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ACM Biolabs
Investment portfolio details for ACM Biolabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ACM Biolabs
Detailed financials for ACM Biolabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acm Biolabs Comparisons
Peer comparison for ACM Biolabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ACM Biolabs
ACM Biolabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, GSK, Avidity Biosciences and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
Detailed competitors of ACM Biolabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acm Biolabs
Complete news archive for ACM Biolabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACM Biolabs
ACM Biolabs was founded in 2012 and raised its 1st funding round 4 years after it was founded.
ACM Biolabs is headquartered in Singapore, Singapore.
Madhavan Nallani is the current CEO of ACM Biolabs. They have also founded this company.
Annual revenue of ACM Biolabs is $33.72K as on May 31, 2018.
ACM Biolabs was founded in 2012 in Singapore within the biotechnology sector. A proprietary artificial polymer-based cell membrane platform has been developed to embed and stabilize functional membrane proteins in environments mimicking native conditions. This technology supports vaccine development by eliciting immune responses and facilitates antibody production targeting membrane proteins. Additionally, targeted drug delivery systems for ocular and transdermal applications are being explored.
ACM Biolabs's top competitors include Moderna, Sutro Biopharma and Adaptive Biotechnologies.
ACM Biolabs offers ATP™ Platform.
ACM Biolabs has 2 investors. Key investors include NTUitive, and Venturelab.